Form 4: Quanterix Director Scott Mendel Receives Equity Grants
Insider Transaction Report
Quanterix Corp Director Scott Mendel reported the acquisition of 25,316 shares of common stock through restricted stock units and stock grants for board service.
Summary
- Scott Mendel, a Director of Quanterix Corp, reported transactions on January 2, 2026, involving the acquisition of company stock.
- Acquired 23,372 restricted stock units (RSUs) which are scheduled to vest 100% on January 2, 2027, in accordance with the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy.
- Acquired an additional 1,944 shares of common stock, granted in lieu of cash fees for service on the Company's Board of Directors and its committees for the fourth quarter of 2025.
- Following these reported transactions, Mendel's beneficial ownership totals 56,053 shares, which includes 47,836 restricted stock units.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. A director receiving equity grants aligns interests with shareholders, but it's a routine compensation event rather than a significant operational or financial announcement.
Positives
- Director Scott Mendel received equity grants, which aligns his financial interests with those of the company's shareholders.
- The use of restricted stock units and stock in lieu of cash fees for director compensation demonstrates a commitment to equity-based incentives for non-employee directors.
Future Outlook
No specific future outlook or guidance is provided in this insider transaction report.
Industry Context
This filing is a routine insider transaction report detailing director compensation and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | Restricted stock units were granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. | 2026-01-02 | Reinforces equity-based compensation for non-employee directors, aligning their interests with long-term shareholder value. |
| Power of Attorney | Scott Mendel granted Power of Attorney to Laurie Churchill, Brian Keane, David Engvall, and Bonnie McManus to execute SEC filings on his behalf. | 2025-07-08 | Standardizes and streamlines the process for insider reporting compliance. |
Stakeholder Impact
- Shareholders: The equity grants to a director further align management's interests with shareholder value creation.
Next Steps
- Vesting of 23,372 restricted stock units on January 2, 2027.
Key Dates
| Date | Description |
|---|---|
| 2025-07-08 | Power of Attorney executed by Scott Mendel, authorizing individuals to file SEC forms on his behalf. |
| 2026-01-02 | Date of reported transactions for the acquisition of restricted stock units and stock in lieu of cash fees. |
| 2026-01-06 | Date the Form 4 was signed by the Attorney-in-Fact. |
| 2027-01-02 | Vesting date for 23,372 restricted stock units granted to Scott Mendel. |
Recommendation
holdThis Form 4 filing details routine equity compensation for a director and does not contain information that would significantly alter the investment thesis for Quanterix Corp. The grants align director interests with shareholders but do not indicate any new operational or financial developments that would warrant a change in investment recommendation.
Keywords
Quanterix, QTRX, Scott Mendel, Director, SEC Form 4, Insider Transaction, Restricted Stock Units, Equity Grant, Stock Compensation, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.